1. Home
  2. COLL vs BMBL Comparison

COLL vs BMBL Comparison

Compare COLL & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • BMBL
  • Stock Information
  • Founded
  • COLL 2002
  • BMBL 2014
  • Country
  • COLL United States
  • BMBL United States
  • Employees
  • COLL N/A
  • BMBL N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • BMBL Computer Software: Prepackaged Software
  • Sector
  • COLL Health Care
  • BMBL Technology
  • Exchange
  • COLL Nasdaq
  • BMBL Nasdaq
  • Market Cap
  • COLL 1.1B
  • BMBL 984.5M
  • IPO Year
  • COLL 2015
  • BMBL 2021
  • Fundamental
  • Price
  • COLL $29.58
  • BMBL $7.87
  • Analyst Decision
  • COLL Strong Buy
  • BMBL Hold
  • Analyst Count
  • COLL 6
  • BMBL 16
  • Target Price
  • COLL $42.00
  • BMBL $8.38
  • AVG Volume (30 Days)
  • COLL 440.1K
  • BMBL 3.0M
  • Earning Date
  • COLL 11-07-2024
  • BMBL 11-06-2024
  • Dividend Yield
  • COLL N/A
  • BMBL N/A
  • EPS Growth
  • COLL 757.11
  • BMBL N/A
  • EPS
  • COLL 2.16
  • BMBL N/A
  • Revenue
  • COLL $599,245,000.00
  • BMBL $1,083,632,000.00
  • Revenue This Year
  • COLL $13.02
  • BMBL $3.72
  • Revenue Next Year
  • COLL $18.01
  • BMBL N/A
  • P/E Ratio
  • COLL $13.68
  • BMBL N/A
  • Revenue Growth
  • COLL 9.62
  • BMBL 6.26
  • 52 Week Low
  • COLL $25.07
  • BMBL $4.80
  • 52 Week High
  • COLL $42.29
  • BMBL $15.90
  • Technical
  • Relative Strength Index (RSI)
  • COLL 26.96
  • BMBL 56.39
  • Support Level
  • COLL $29.69
  • BMBL $8.11
  • Resistance Level
  • COLL $35.62
  • BMBL $9.16
  • Average True Range (ATR)
  • COLL 1.41
  • BMBL 0.42
  • MACD
  • COLL -0.39
  • BMBL 0.04
  • Stochastic Oscillator
  • COLL 6.36
  • BMBL 39.24

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect.

Share on Social Networks: